Global Health Ltd

Global Health Ltd

Global Health Ltd has issued certificates under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, stating that there were no securities dematerialized or rematerialized during the period.

Global Health Ltd

Global Health Ltd has received an ESG rating of 'Crisil ESG 64' and Core ESG rating of 'Crisil Core ESG 70' for FY 2026 from Crisil ESG Ratings & Analytics Limited.

Global Health Ltd

Global Health Ltd (Medanta) has acquired a 10,560 sq. meter land parcel in Ghaziabad, Uttar Pradesh, for ₹165.82 crore to develop a 350+ bedded hospital, strengthening its presence in the Delhi-NCR healthcare market.

Global Health Ltd

Global Health Ltd has been allotted a land parcel from UP Housing & Development Board for Rs 165.82 crores to construct a 350+ bedded hospital, subject to approvals.

Global Health Ltd

Global Health Ltd has announced the closure of its trading window for the second quarter ended September 30, 2026, in accordance with SEBI regulations and the company's code for prevention of insider trading. The trading window will remain closed from October 1, 2026, and will reopen after 48 hours from the declaration of unaudited financial results.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 25, 2026, to be held virtually with Arohi Asset Management. No unpublished price-sensitive information will be shared.

Global Health Ltd

Global Health Ltd has informed about the allotment of 3,000 equity shares under the GHL-Employee Long Term Share Based Incentive Plan 2024 to GHL Employees Welfare Trust. The shares will be transferred to eligible employees' Demat Account as per the provisions of the Scheme. The paid-up share capital of the Company has increased from Rs. 53,77,43,564/- to Rs. 53,77,49,564/-.

Global Health Ltd

Global Health Ltd has announced the voting results of its 22nd Annual General Meeting, which was held through video conferencing on September 16, 2026. The meeting was conducted in compliance with SEBI and MCA regulations, and the company has provided a scrutinizer's report on the e-voting process.

Global Health Ltd

Global Health Ltd held its 22nd Annual General Meeting (AGM) on September 16, 2026, through video conferencing. The meeting approved the audited standalone and consolidated financial statements for FY 2025-26, declared a final dividend of ₹ 0.50 per equity share, and appointed a new director. The company also approved the remuneration of its cost auditors for FY 2026-27.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced a meeting with investors and analysts on September 14, 2026, in Lucknow, organized by Jefferies. The meeting is subject to change due to unforeseen circumstances and no unpublished price-sensitive information will be shared.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet, to be held on September 10 and 14, 2026, in Gurugram, with no unpublished price sensitive information to be shared.

Global Health Ltd

Global Health Ltd, a healthcare company, has announced a schedule for meeting with investors and analysts on September 10 and 14, 2026, in Gurugram. The meetings are to be held in person and are subject to change due to unforeseen circumstances.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, with no unpublished price sensitive information to be shared.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, where the company's management will meet investors and analysts. The meeting is subject to change due to unforeseen circumstances.

Global Health Ltd

Global Health Ltd (MEDANTA) has announced an institutional investor meet on August 31, 2026, in Noida, to be held in person. The meeting is organized by Prabhudas Lilladher Capital, and no unpublished price-sensitive information will be shared.

Global Health Ltd

Global Health Ltd (MEDANTA) has scheduled an analyst/institutional investor meeting on August 26-27, 2026, with Motilal Oswal Financial Services, without sharing unpublished price-sensitive information.

Global Health Ltd

Global Health Ltd has announced an institutional investor meet, scheduled for August 26 and 27, 2026, where the company's management will meet with investors and analysts. The meeting will be held in physical mode, and no unpublished price-sensitive information will be shared.

Global Health Ltd

Global Health Ltd has published a newspaper advertisement confirming the dispatch of AGM notice and annual report for the financial year 2025-26.

Global Health Ltd

Global Health Ltd has dispatched a letter to shareholders providing the weblink of Annual Report for the FY 2025-26, as per SEBI Listing Regulations. The 22nd Annual General Meeting (AGM) is scheduled to be held on September 16, 2026, through Video Conference (VC) / Other Audio-Visual Means (OAVM).

Global Health Ltd

Global Health Ltd, the parent company of Medanta, a multi-specialty tertiary care provider, has released its Business Responsibility and Sustainability Report for the financial year 2025-26, along with a Reasonable Assurance Report. The report highlights the company's corporate identity, business activities, operational footprint, workforce profile, and holding/subsidiary structure. The report also sets out the company's linkage with capitals, including patients, employees, shareholders, financial capital, human capital, and manufactured capital.